Different circulating levels of monocyte chemoattractant protein-1 and interleukin-8 during the menopausal transition

Cytokine

Volumn 62, Issue 1, 2013, Pages 86-90

  Tani, Anna ^a   Yasui, Toshiyuki ^a   Matsui, Sumika ^a   Kato, Takeshi ^a   Kunimi, Kotaro ^a   Tsuchiya, Naoko ^b   Yuzurihara, Mitsutoshi ^b   Kase, Yoshio ^b   Irahara, Minoru ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b Tsumura Research Institute   (Japan)

Author keywords

Interleukin 8; Menopausal transition; Monocyte chemoattractant protein 1

Indexed keywords

ESTRADIOL; FOLLITROPIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; LUTEINIZING HORMONE; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CLIMACTERIUM; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE COURSE; FEMALE; HORMONE DETERMINATION; HUMAN; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION;

ADULT; AGED; CHEMOKINE CCL2; CHEMOKINES; ESTRADIOL; FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; INTERLEUKIN-8; LUTEINIZING HORMONE; MENOPAUSE; MIDDLE AGED;

EID: 84875813763     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2013.02.011     Document Type: Article

References (37)

1. de Bont N., Netea M.G., Rovers C., Smilde T., Demacker P.N., van der Meer J.W., et al. LPS-induced cytokine production and expression of LPS-receptors by peripheral blood mononuclear cells of patients with familial hypercholesterolemia and the effect of HMG-CoA reductase inhibitors. Atherosclerosis 1998, 139:147-152.
2. Barks J.L., McQuillan J.J., Iademarco M.F. TNF-α and IL-4 synergistically increase vascular cell adhesion molecule-1 expression in cultured vascular smooth muscle cells. J. Immunol. 1997, 159:4532-4538.
3. Pacifici R. Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis. J. Bone. Miner. Res. 1996, 11:1043-1051.
4. Horwood N.J., Udagawa N., Elliott J., Grail D., Okamura H., Kurimoto M., et al. Interleukin 18 inhibits osteoclast formation via T cell production of granulocyte-macrophage colony-stimulating factor. J. Clin. Invest. 1998, 101:595-603.
5. Mallat Z., Heymes C., Ohan J., Faggin E., Lesèche G., Tedgui A. Expression of interleukin-10 in advanced human atherosclerotic plaques: relation to inducible nitric oxide synthase expression and cell death. Arterioscler. Thromb. Vasc. Biol. 1999, 19:611-616.
6. Lakoski S.G., Liu Y., Brosnihan K.B., Herrington D.M. Interleukin-10 concentration and coronary heart disease (CHD) event risk in the estrogen replacement and atherosclerosis (ERAs) study. Atherosclerosis 2008, 197:443-447.
7. Schiepers O.J.G., Wichers M.C., Maes M. Cytokines and major depression. Prog. Neuro-Psychopharmacol. Biol. Psychiatr. 2005, 29:201-217.
8. Yasui T., Uemura H., Tomita J., Miyatani Y., Yamada M., Kuwahara A., et al. Association of interleukin-8 with hot flashes in premenopausal, perimenopausal, and postmenopausal women and bilateral oophorectomized women. J. Clin. Endocrinol. Metab. 2006, 91:4805-4808.
9. Maes M., Meltzer H.Y., Bosmans E., Bergmans R., Vandoolaeghe E., Ranjan R., et al. Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression. J. Affect. Disord. 1995, 34:301-309.
10. Cioffi M., Esposito K., Vietri M.T., Gazzerro P., D'auria A., Ardovino I., et al. Cytokine pattern in postmenopause. Maturitas 2002, 41:187-192.
11. Kamada M., Irahara M., Maegawa M., Ohmoto Y., Takeji T., Yasui T., et al. Postmenopausal changes in serum cytokine levels and hormone replacement therapy. Am. J. Obstet. Gynecol. 2001, 184:309-314.
12. Yasui T., Maegawa M., Tomita J., Miyatani Y., Yamada M., Uemura H., et al. Changes in serum cytokine concentrations during the menopausal transition. Maturitas 2007, 56:396-403.
13. Soules M.R., Sherman S., Parrott E., Rebar R., Santoro N., Utian W., et al. Executive summary: stage of reproductive aging workshop (STRAW). Fertil. Steril. 2001, 76:788-874.
14. Ligthart G.J., Corberand J.X., Fournier C., Galanaud P., Hijmans W., Kennes B., et al. Admission criteria for immunogerontological studies in man: the SENIEUR protocol. Mech. Ageing. Dev. 1984, 28:47-55.
15. Tedgui A., Mallat Z. Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol. Rev. 2006, 86:515-581.
16. Gerszten R.E., Garcia-Zepeda E.A., Lim Y.C., Yoshida M., Ding H.A., Gimbrone M.A., et al. MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow condition. Nature 1999, 398:718-723.
17. Charo I.F., Taubman M.B. Chemokines in the pathogenesis of vascular disease. Circ. Res. 2004, 95:858-866.
18. Botti C., Maione C., Dogliotti G., Russo P., Signoriello G., Molinari A.M., et al. Circulating cytokines present in the serum of peripheral arterial disease patients induce endothelial dysfunction. J. Biol. Regul. Homeost. Agents. 2012, 26:67-79.
19. Seli E., Pehlivan T., Selam B., Garcia-Velasco J.A., Arici A. Estradiol down-regulates MCP-1 expression in human coronary artery endothelial cells. Fertil. Steril. 2002, 77:542-547.
20. Miller A.P., Feng W., Xing D., Weathington N.M., Blalock J.E., Chen Y.F., et al. Estrogen modulates inflammatory mediator expression and neutrophil chemotaxis in injured arteries. Circulation 2004, 110:1664-1669.
21. Jiang P., Wu J., Zheng S., Huang J., Xiang Q., Fu X., et al. 17-estradiol down-regulates lipopolysaccharide-induced MCP-1 production and cell migration in vascular smooth muscle cells. J. Molecul. Endocrinol. 2010, 45:87-97.
22. Yasui T., Saijo A., Uemura H., Matsuzaki T., Tsuchiya N., Yuzurihara M., et al. Effects of oral and transdermal estrogen therapies on circulating cytokines and chemokines in postmenopausal women with hysterectomy. Eur. J. Endocrinol. 2009, 161:267-273.
23. Miyatani Y., Yasui T., Uemura H., Yamada M., Matsuzaki T., Kuwahara A., et al. Associations of circulating adiponectin with estradiol and monocyte chemotactic protein-1 in postmenopausal women. Menopause 2008, 15:536-541.
24. Matsui S., Yasui T., Uemura H., Yamamoto S., Matsuzaki T., Tsuchiya N., et al. Induction of circulating monocyte chemoattractant protein-1 in women with gonadotropin-releasing hormone agonist. J. Reprod. Immunol. 2011, 90(2011):227-234.
25. Menten P., Wuyts A., Van Damme J. Macrophage inflammatory protein-1. Cytokine Growth Factor Rev. 2002, 13:455-481.
26. Aukrust P., Halvorsen B., Yndestad A., Ueland T., Øie E., Otterdal K., et al. Chemokines and cardiovascular risk. Arterioscler. Thromb Vasc. Biol. 2008, 28:1909-1919.
27. Kim C.S., Parks H.S., Kawada T., Kim J.H., Lim D., Hubbard N.E., et al. Circulating levels of MCP-1 and IL-8 are elevated in human obese subjects and associated with obesity-related parameters. Int. J. Obes. 2006, 30:1347-1355.
28. Yang Q.W., Mou L., Lv F.L., Wang L., Zhou H.J., Gao D. Role of Toll-like receptor 4/NF-kappaB pathway in monocyte-endothelial adhesion induced by low shear stress and ox-LDL. Biorheology 2005, 42:225-236.
29. Bruun J.M., Lihn A.S., Madan A.K., Pedersen S.B., Schiøtto K.M., Fain J.N., et al. Higher production of IL-8 in visceral vs. subcutaneous adipose tissue. Implication of nonadipose cells in adipose tissue. Am. J. Physiol. Endocrinol. Metab. 2004, 286:E8-E13.
30. Noguchi M., Yuzurihara M., Kase Y., Yasui T., Irahara M. Involvement of cytokine-induced neutrophil chemoattractant in hypothalamus thermoregulation of luteinizing hormone-releasing hormone. Endocrinology 2008, 149:2899-2906.
31. Ariel A., Hershkoviz R., Cahalon L., Williams D.E., Akiyama S.K., Yamada K.M., et al. Induction of T cell adhesion to extracellular matrix or endothelial cell ligands by soluble or matrix-bound interleukin-7. Eur. J. Immunol. 1997, 27:2562-2570.
32. Duś D., Krawczenko A., Zaecki P., Paprocka M., Wiedocha A., Goupille C., et al. IL-7 receptor is present on human microvascular endothelial cells. Immunol. Lett. 2003, 68:163-168.
33. Weitzmann M.N., Roggia C., Toraldo G., Weitzmann L., Pacifici R. Increased production of IL-7 uncouples bone formation from bone resorption during estrogen deficiency. J. Clin. Invest. 2002, 110:1643-1650.
34. Yasui T., Uemura H., Hyodo S., Yamada M., Yamamoto S., Maegawa M., et al. Raloxifene reduces circulating levels of interleukin-7 and monocyte chemoattractant protein-1 in postmenopausal women. Atherosclerosis 2009, 204:471-475.
35. Kumru S., Godekmerdan A., Yilmaz B. Immune effects of surgical menopause and estrogen replacement therapy in peri-menopausal women. J. Reprod. Immunol. 2004, 63:31-38.
36. Abu-Taha M., Rius C., Hermenegilbo C., Noguera I., Cerda-Nicolas J.M., Issekutz A.C., et al. Menopause and ovariectomy cause a low grade of systemic inflammation that may be prevented by chronic treatment with low doses of estrogen or losartan. J. Immunol. 2009, 183:1393-1402.
37. Judd H.L., Judd G.E., Lucas W.E., Yen S.S. Endocrine function of the postmenopausal ovary: concentration of androgens and estrogens in ovarian and peripheral vein blood. J. Clin. Endocrinol. Metab. 1974, 39:1020-1024.